Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, & Qinjie Weng. (2022). Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Elsevier.
Chicago Style (17th ed.) CitationJincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, and Qinjie Weng. Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis. Elsevier, 2022.
MLA (9th ed.) CitationJincheng Wang, et al. Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.